253 related articles for article (PubMed ID: 26298430)
21. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
[TBL] [Abstract][Full Text] [Related]
22. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
23. Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression.
Napoletano C; Bellati F; Landi R; Pauselli S; Marchetti C; Visconti V; Sale P; Liberati M; Rughetti A; Frati L; Panici PB; Nuti M
J Cell Mol Med; 2010 Dec; 14(12):2748-59. PubMed ID: 19780872
[TBL] [Abstract][Full Text] [Related]
24. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
25. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
26. Association between effector-type regulatory T cells and immune checkpoint expression on CD8
Sato S; Matsushita H; Shintani D; Kobayashi Y; Fujieda N; Yabuno A; Nishikawa T; Fujiwara K; Kakimi K; Hasegawa K
BMC Cancer; 2022 Apr; 22(1):437. PubMed ID: 35449092
[TBL] [Abstract][Full Text] [Related]
27. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
Charbonneau B; Moysich KB; Kalli KR; Oberg AL; Vierkant RA; Fogarty ZC; Block MS; Maurer MJ; Goergen KM; Fridley BL; Cunningham JM; Rider DN; Preston C; Hartmann LC; Lawrenson K; Wang C; Tyrer J; Song H; deFazio A; Johnatty SE; Doherty JA; Phelan CM; Sellers TA; Ramirez SM; Vitonis AF; Terry KL; Van Den Berg D; Pike MC; Wu AH; Berchuck A; Gentry-Maharaj A; Ramus SJ; Diergaarde B; Shen H; Jensen A; Menkiszak J; Cybulski C; Lubiłski J; Ziogas A; Rothstein JH; McGuire V; Sieh W; Lester J; Walsh C; Vergote I; Lambrechts S; Despierre E; Garcia-Closas M; Yang H; Brinton LA; Spiewankiewicz B; Rzepecka IK; Dansonka-Mieszkowska A; Seibold P; Rudolph A; Paddock LE; Orlow I; Lundvall L; Olson SH; Hogdall CK; Schwaab I; du Bois A; Harter P; Flanagan JM; Brown R; Paul J; Ekici AB; Beckmann MW; Hein A; Eccles D; Lurie G; Hays LE; Bean YT; Pejovic T; Goodman MT; Campbell I; Fasching PA; Konecny G; Kaye SB; Heitz F; Hogdall E; Bandera EV; Chang-Claude J; Kupryjanczyk J; Wentzensen N; Lambrechts D; Karlan BY; Whittemore AS; Culver HA; Gronwald J; Levine DA; Kjaer SK; Menon U; Schildkraut JM; Pearce CL; Cramer DW; Rossing MA; Chenevix-Trench G; ; ; Pharoah PD; Gayther SA; Ness RB; Odunsi K; Sucheston LE; Knutson KL; Goode EL
Cancer Immunol Res; 2014 Apr; 2(4):332-40. PubMed ID: 24764580
[TBL] [Abstract][Full Text] [Related]
28. Changes in regulatory T cells in patients with ovarian cancer undergoing surgery: Preliminary results.
Wu M; Chen X; Lou J; Zhang S; Zhang X; Huang L; Sun R; Huang P; Pan S; Wang F
Int Immunopharmacol; 2017 Jun; 47():244-250. PubMed ID: 28437737
[TBL] [Abstract][Full Text] [Related]
29. TIGIT enhances CD4
Chen F; Xu Y; Chen Y; Shan S
Cancer Med; 2020 May; 9(10):3584-3591. PubMed ID: 32212317
[TBL] [Abstract][Full Text] [Related]
30. Effects of Treg cells and IDO on human epithelial ovarian cancer cells under hypoxic conditions.
Liu J; Zhang H; Jia L; Sun H
Mol Med Rep; 2015 Mar; 11(3):1708-14. PubMed ID: 25376937
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the treg cell population in the peripheral blood of ovarian cancer patients in relation to the long-term outcomes.
Dutsch-Wicherek MM; Szubert S; Dziobek K; Wisniewski M; Lukaszewska E; Wicherek L; Jozwicki W; Rokita W; Koper K
Ginekol Pol; 2019; 90(4):179-184. PubMed ID: 31059109
[TBL] [Abstract][Full Text] [Related]
32. Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway.
Li L; Ma Y; Xu Y
Int Immunopharmacol; 2019 Mar; 68():81-87. PubMed ID: 30616170
[TBL] [Abstract][Full Text] [Related]
33. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.
Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of human leukocyte antigen class I expression and association of platinum resistance with immunologic profiles in epithelial ovarian cancer.
Mariya T; Hirohashi Y; Torigoe T; Asano T; Kuroda T; Yasuda K; Mizuuchi M; Sonoda T; Saito T; Sato N
Cancer Immunol Res; 2014 Dec; 2(12):1220-9. PubMed ID: 25324403
[TBL] [Abstract][Full Text] [Related]
36. Increased tumor-infiltrating CD45RA
Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
[TBL] [Abstract][Full Text] [Related]
37. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of allogeneic cytotoxic T cell (CD8
Kang N; Toyofuku WM; Yang X; Scott MD
Acta Biomater; 2017 Jul; 57():146-155. PubMed ID: 28442414
[TBL] [Abstract][Full Text] [Related]
39. Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients.
Landskron J; Helland Ø; Torgersen KM; Aandahl EM; Gjertsen BT; Bjørge L; Taskén K
Cancer Immunol Immunother; 2015 Mar; 64(3):337-47. PubMed ID: 25416072
[TBL] [Abstract][Full Text] [Related]
40. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
Zhang HH; Guo F; Fei R; Ma H; Cong X; Wei L; Chen HS
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):511-5. PubMed ID: 18649763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
